Corrigendum: Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients (American Journal of Gastroenterology (2016) 111 (1456-1465) DOI: 10.1038/ajg.2016.439);Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients

American Journal of Gastroenterology

Volumn 111, Issue 10, 2016, Pages 1456-1465

  Comino, Isabel ^a   Fernández Bañares, Fernando ^b   Esteve, María ^b   Ortigosa, Luís ^c   Castillejo, Gemma ^d   Fambuena, Blanca ^e   Ribes Koninckx, Carmen ^f   Sierra, Carlos ^g   Rodríguez Herrera, Alfonso ^h   Salazar, José Carlos ⁱ   Caunedo, Ángel ^j   Marugan Miguelsanz J M ^k   Garrote, José Antonio ^l   Vivas, Santiago ^m   Lo Iacono, Oreste ⁿ   Nuñez, Alejandro ^m   Vaquero, Luis ^m   Vegas, Ana María ^l   Crespo, Laura ^l   Fernández Salazar, Luis ^k   Arranz, Eduardo ^k   Jiménez García, Victoria Alejandra ^j   Antonio Montes Cano, Marco ^o   Espín, Beatriz ⁱ   Galera, Ana ^h   Valverde, Justo ^h   Girón, Francisco José ^g   Bolonio, Miguel ^f   Millán, Antonio ^e   Cerezo, Francesc Martínez ^d   Guajardo, César ^c   Alberto, José Ramón ^c   Rosinach, Mercé ^b   Segura, Verónica ^a   León, Francisco ^p   Marinich, Jorge ^q   Muñoz Suano, Alba ^q   Romero Gómez, Manuel ^e   Cebolla, Ángel ^q   Sousa, Carolina ^a   more..

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^g HOSPITAL MATERNO INFANTIL   (Spain)

^h Instituto Hispalense de Pediatria   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^k UNIVERSITY OF VALLADOLID   (Spain)

^l HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^m HOSPITAL UNIVERSITARIO DE LEÓN   (Spain)

ⁿ Aranjuez   (Spain)

^o CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^p Celimmune   (United States)

^q Biomedal SL   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIBODY; AUTOANTIBODY; GLIADIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FECES LEVEL; FEMALE; FOOD INTAKE; GLUTEN FREE DIET; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITIONAL ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SEROLOGY; AGE; CASE CONTROL STUDY; CHEMISTRY; DIET THERAPY; FECES; IMMUNOLOGY; INFANT; MEDICAL RECORD; PATIENT COMPLIANCE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; ANTIBODIES; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET RECORDS; DIET, GLUTEN-FREE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GLIADIN; GLUTENS; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; INFANT; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SEROLOGIC TESTS; SURVEYS AND QUESTIONNAIRES; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84988661192     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2017.110     Document Type: Erratum

References (35)

1. Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr 2014; 59: S7-9.
2. Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 2013; 13: 294-302.
3. Lundin KE, Qiao SW, Snir O et al. Coeliac disease-from genetic and immunological studies to clinical applications. Scand J Gastroenterol 2015; 50: 708-17.
4. Vriezinga SL, Schweizer JJ, Koning F et al. Coeliac disease and glutenrelated disorders in childhood. Nat Rev Gastroenterol Hepatol 2015; 12: 527-36.
5. Ludvigsson JF, Bai JC, Biagi F et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014; 63: 1210-28.
6. Ciacci C, Cirillo M, Cavallaro R et al. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002; 66: 178-85.
7. Hogberg L, Grodzinsky E, Stenhammar L. Better dietary compliance in patients with coeliac disease diagnosed in early childhood. Scand J Gastroenterol 2003; 38: 751-4.
8. Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology 2005; 128: 135-41.
9. Herman ML, Rubio-Tapia A, Lahr BD et al. Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol 2012; 10: 893-9.
10. Galli G, Esposito G, Lahner E et al. Histological recovery and gluten-free diet adherence: a prospective 1-year follow-up study of adult patients with coeliac disease. Aliment Pharmacol Ther 2014; 40: 639-47.
11. Husby S, Koletzko S, Korponay-Szabo IR et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-60.
12. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000; 95: 712-4.
13. Kaukinen K, Sulkanen S, Maki M et al. IgA-class transglutaminase antibodies in evaluating the effi cacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002; 14: 311-5.
14. Kaukinen K, Peraaho M, Lindfors K et al. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther 2007; 25: 1237-45.
15. Vahedi K, Mascart F, Yves JM et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003; 98: 1079-87.
16. Bannister EG, Cameron DJ, Ng J et al. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet? Am J Gastroenterol 2014; 109: 1478-83.
17. Moron B, Cebolla A, Manyani H et al. Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. Am J Clin Nutr 2008; 87: 405-14.
18. Moron B, Bethune MT, Comino I et al. Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One 2008; 3: e2294.
19. Comino I, Real A, Vivas S et al. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr 2012; 95: 670-7.
20. Armbruster D, Terry P. Limit of blank, limit of detection and limit of quantitation. Clin Biochemist Rev 2008; 29: S49-52.
21. Comino I, Real A, de Lorenzo L et al. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut 2011; 60: 915-22.
22. Comino I, Real A, Gil-Humanes J et al. Signifi cant diff erences in coeliac immunotoxicity of barley varieties. Mol Nutr Food Res 2012; 56: 1697-707.
23. Comino I, Real A, Moreno ML et al. Immunological determination of gliadin 33-mer equivalent peptides in beers as a specifi c and practical analytical method to assess safety for celiac patients. J Sci Food Agric 2013; 93: 933-43.
24. Real A, Comino I, Moreno ML et al. Identifi cation and in vitro reactivity of celiac immunoactive peptides in an apparent gluten-free beer. PLoS One 2014; 9: e100917.
25. Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microb Rev 2010; 23: 550-76.
26. Urgesi R, Cianci R, Bizzotto A et al. Evaluation of gastric and small bowel transit times in coeliac disease with the small bowel PillCamR: a single centre study in a non gluten-free Diet adult italian population with coeliac disease. Eur Rev Medical Pharmacol Sci 2013; 17: 1167-73.
27. Wagener S, Shankar KR, Turnock RR et al. Colonic transit time-what is normal? J Pediatr Surg 2004; 39: 166-9.
28. Leffl er DA, Dennis M, Hyett B et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007; 5: 445-50.
29. Hall NJ, Rubin GP, Charnock A. Intentional and inadvertent nonadherence in adult coeliac disease. A cross-sectional survey. Appetite 2013; 68: 56-62.
30. Haines ML, Anderson RP, Gibson PR. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008; 28: 1042-66.
31. Sharkey LM, Corbett G, Currie E et al. Optimising delivery of care in coeliac disease-comparison of the benefi ts of repeat biopsy and serological follow-up. Aliment Pharmacol Ther 2013; 38: 1278-91.
32. Dickey W, Hughes DF, McMillan SA. Patients with serum IgA endomysial antibodies and intact duodenal villi: clinical characteristics and management options. Scand J Gastroenterol 2005; 40: 1240-3.
33. Hopper AD, Hadjivassiliou M, Hurlstone DP et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confi rmed study wiTheconomic analysis. Clin Gastroenterol Hepatol 2008; 6: 314-20.
34. Lahdeaho ML, Maki M, Laurila K et al. Small-bowel mucosal changes and antibody responses aft er low-and moderate-dose gluten challenge in celiac disease. BMC Gastroenterol 2011; 11: 129.
35. Moreno ML, Cebolla A, Munoz-Suano A et al. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut 2015; doi:10. 1136/gutjnl-2015-310148.